A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital

Clinical Infectious Diseases

Volumn 29, Issue 1, 1999, Pages 96-101

  Sacks, Leonard V ^a,b   Pendle, Stella ^a,b   Orlovic, Dragana ^a,b   Blumberg, Lucille ^a,b   Constantinou, Constantinos ^a,b  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b Division of Special Pathogens   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA FINGERPRINTING; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0032766001     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520189     Document Type: Article

References (28)

1. 1. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-21.
2. 2. Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992;117:177-83.
3. 3. Buck-Sague, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. JAMA 1992;268:1280-86.
4. 4. Ritacco V, Di Leonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug resistant tuberculosis in Buenos Aires. J Infect Dis 1997;176:637-42.
5. 5. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med 1992;117:191-6.
6. 6. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231-5.
7. 7. Frieden TR, Sherman L, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996;276:1229-35.
8. 8. Agerton T, Valway S, Gore B, et al. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. JAMA 1997;278:1073-7.
9. 9. Selvaraj P, Reetha AM, Uma H, et al. Influence of HLA-DR and -DO phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tubercle Lung Dis 1996;77:369-73.
10. 10. Goldfeld AE, Delgado JC, Thim S, et al. Association of an HLA DQ allele with clinical tuberculosis. JAMA 1998;279:226-8.
11. 11. Bellamy R, Ruwende C, Corrah T, McAdam K, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4.
12. 12. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997;24(suppl I):S121-30.
13. 13. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994 1997. N Engl J Med 1998;338:1641-9.
14. 14. Sacks LV, Pendle S. Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med 1998;158:1916-22.
15. 15. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1993;29:2578-86.
16. 16. van Soolingen D, de Haas PEW, Hermans PWM, Groenen PMA, van Embden JDA. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1993;31:1987-95.
17. 17. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43.
18. 18. Roberts G, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983;18:689-96.
19. 19. Epi Info, version 6. Atlanta: Centers for Disease Control and Prevention, 1994.
20. 20. Guerrero A, Cobo J, Fortun J, et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 1997;350:1738-42.
21. 21. Glynn JR, Jenkins PA, Fine PEM, et al. Patterns of initial and acquired antituberculosis drug resistance in Karonga district, Malawi. Lancet 1995;345:907-10.
22. 22. Braun MM, Kilburn JO, Smithwick RW, et al. HIV infection and primary resistance to antituberculosis drugs in Abidjan, Cote d'Ivoire. AIDS 1992;6:1327-30.
23. 23. Fishman JE, Sais GJ, Schwartz DS, Otten J. Radiographic findings and patterns in multi-drug resistant tuberculosis. J Thorac Imaging 1998;13:65-71.
24. 24. Gallant JE, Ko AH. Cavitary pulmonary lesions in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;22:671-82.
25. 25. Valway SE, Sanchez MPC, Shinnick TF, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998;338:633-9.
26. 26. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR Morbid Mortal Wkly Rep 1994;43(RR 13):1-132.
27. 27. Coetzee N, Mahomed H. Prevention of tuberculosis transmission in health care facilities. S Afr Med J 1995;85:115.
28. 28. Department of Health (South Africa). Report of the review of the tuberculosis control programme of South Africa, 10 25 June 1996. Epidemiological Comments 1996;23:2-18.